Sertraline for HIV-associated cryptococcal meningitis - Authors' reply
- PMID: 27676347
- PMCID: PMC5367916
- DOI: 10.1016/S1473-3099(16)30340-1
Sertraline for HIV-associated cryptococcal meningitis - Authors' reply
Conflict of interest statement
We declare no competing interests.
Figures
Comment on
-
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.Lancet Infect Dis. 2016 Jul;16(7):809-818. doi: 10.1016/S1473-3099(16)00074-8. Epub 2016 Mar 10. Lancet Infect Dis. 2016. PMID: 26971081 Free PMC article. Clinical Trial.
-
Sertraline for HIV-associated cryptococcal meningitis.Lancet Infect Dis. 2016 Oct;16(10):1111. doi: 10.1016/S1473-3099(16)30321-8. Epub 2016 Sep 19. Lancet Infect Dis. 2016. PMID: 27676346 No abstract available.
References
-
- Morawski BM, Boulware DR, Nalintya E, et al. Pre-ART Cryptococcal Antigen Titer Associated With Preemptive Fluconazole Failure. Conference on Retroviruses and Opportunistic Infections (CROI); Boston, MA. 2016.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
